nifekalant hydrochloride has been researched along with Tachycardia, Ventricular in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (10.81) | 18.2507 |
| 2000's | 23 (62.16) | 29.6817 |
| 2010's | 8 (21.62) | 24.3611 |
| 2020's | 2 (5.41) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Tao, L; Xiao, H | 1 |
| Di, C; Gao, P; Lin, W; Wang, Q; Wu, Y | 1 |
| Chuma, M; Imai, T; Ishizawa, K; Izawa-Ishizawa, Y; Koga, T; Kondo, Y; Koyama, T; Kurata, Y; Nakura, H; Niimura, T; Sato, S; Sendo, T; Takechi, K; Tanaka, S; Zamami, Y | 1 |
| Koyfman, A; Long, B | 1 |
| Maeda, K; Nakagawa, E; Takagi, M; Tatsumi, H; Yoshiyama, M | 1 |
| Enjoji, Y; Funatsu, A; Kambayashi, D; Kobayashi, T; Mizobuchi, M; Nakamura, S; Ono, T; Yamamoto, R | 1 |
| Abe, A; Ikeda, T; Ishiguro, H; Mera, H; Miwa, Y; Miyakoshi, M; Shimizu, H; Tsukada, T; Yoshino, H; Yusu, S | 1 |
| Amino, M; Honda, T; Kasanuki, H; Kato, R; Katoh, T; Matsudo, Y; Ogawa, S; Sagara, K; Shiga, T; Takahashi, A; Takano, T; Tanaka, K; Urashima, M | 1 |
| Hisahara, M; Ikeuchi, M; Kozai, T; Kurisu, K; Onitsuka, H; Sekiya, M; Urabe, Y | 1 |
| Chen, KP; Hua, W; Pu, JL; Wang, FZ; Wang, J; Yang, YM; Zhang, S; Zhu, J | 1 |
| Aono, H; Furukawa, H; Iwasaki, K; Ohkado, A; Samukawa, M | 1 |
| Nagao, K | 1 |
| Ajiki, K; Hayami, N; Inaba, H; Kunishima, T; Mikamo, T; Murakawa, Y; Sugiura, A; Tsutsui, K; Watanabe, H; Yamagishi, N; Yamagishi, S | 1 |
| Ohnishi, S | 1 |
| Aonuma, K; Hiraoka, M; Hiroe, M; Igawa, M; Isobe, M; Okamoto, Y | 1 |
| Amino, M; Ban, K; Deguchi, Y; Fujikura, H; Goto, S; Handa, S; Inokuchi, S; Iwase, H; Iwata, O; Marutani, Y; Morita, S; Nakagawa, Y; Shiina, Y; Tanabe, T; Yamamoto, I; Yoshioka, K | 1 |
| Fu, LT; Iinuma, H; Sagara, K; Sahara, M; Watanabe, H; Yamashita, T | 1 |
| Kamakura, S; Kawamura, A; Kurita, T; Miyazaki, S; Morii, I; Myoishi, M; Nonogi, H; Otsuka, Y; Satomi, K; Ueno, K; Yasuda, S | 1 |
| Iwasa, S; Sakaguchi, M; Shimamura, Y; Takemura, T; Tsuda, Y | 1 |
| Hotoda, K; Kokaji, K; Kumamaru, H; Okamoto, M | 1 |
| Aoki, K; Asakura, T; Enomoto, Y; Furuta, S; Inai, Y; Toshimitsu, Y | 1 |
| Ando, J; Iwabuchi, M; Kakishita, M; Komura, Y; Nishiyama, K; Nobuyoshi, M; Nosaka, H; Sakai, K; Yasumoto, H; Yokoi, H | 1 |
| Honjo, H; Ishiguro, Y; Kamiya, K; Kodama, I; Nakagawa, H; Okuno, Y; Sakuma, I; Yamazaki, M | 1 |
| Aizawa, Y; Chinushi, M; Furushima, H; Hirono, T; Hosaka, Y; Komura, S; Sugiura, H; Tanabe, Y; Washizuka, T; Watanabe, H | 2 |
| Amino, M; Deguchi, Y; Ikari, Y; Inokuchi, S; Kodama, I; Matsuzaki, A; Morita, S; Nakagawa, Y; Sugimoto, A; Tanabe, T; Usui, K; Yamamoto, I; Yoshioka, K | 1 |
| Hamano, K; Murakami, M; Nishida, M; Okada, H | 1 |
| Sugi, K | 1 |
| Amino, M; Honjo, H; Ishiguro, YS; Kamiya, K; Kodama, I; Nakagawa, H; Okuno, Y; Sakuma, I; Yamazaki, M | 1 |
| Amino, M; Deguchi, Y; Ikari, Y; Kanda, S; Kodama, I; Kohzuma, K; Matsuzaki, A; Sugimoto, A; Tanabe, T; Usui, K; Yoshioka, K | 1 |
| Kato, H; Makino, Y; Murakami, T | 1 |
| Fukuhara, S; Makino, K; Morimoto, A; Nakagawa, Y; Takase, E; Tateishi, E; Umeda, M; Yamamoto, K; Yokoyama, K | 1 |
| Hashimoto, H; Kondoh, K; Nakashima, M; Nishiyama, H; Ozaki, T; Uematsu, T; Umemura, K | 1 |
| Aizawa, Y; Naitoh, N; Takahashi, K; Washizuka, T | 1 |
| Aizawa, Y; Furushima, H; Naitoh, N; Tagawa, M; Taneda, K; Yamaura, M | 2 |
| Ando, S; Kasanuki, H; Matsuda, N; Shiga, T; Suzuki, T | 1 |
5 review(s) available for nifekalant hydrochloride and Tachycardia, Ventricular
| Article | Year |
|---|---|
Meta-analysis of the efficacies of amiodarone and nifekalant in shock-resistant ventricular fibrillation and pulseless ventricular tachycardia.
Topics: Amiodarone; Humans; Publication Bias; Pulse; Pyrimidinones; Randomized Controlled Trials as Topic; Survival Analysis; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation | 2017 |
Best Clinical Practice: Emergency Medicine Management of Stable Monomorphic Ventricular Tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electric Countershock; Electrocardiography; Emergency Service, Hospital; Evidence-Based Medicine; Humans; Lidocaine; Procainamide; Pyrimidinones; Review Literature as Topic; Sotalol; Tachycardia, Ventricular | 2017 |
[Management of lethal ventricular arrhythmias after cardiac surgery].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Catheter Ablation; Humans; Intra-Aortic Balloon Pumping; Postoperative Complications; Pyrimidinones; Recurrence; Tachycardia, Ventricular; Ventricular Fibrillation | 2002 |
Optical imaging of spiral waves: pharmacological modification of spiral-type excitations in a 2-dimensional layer of ventricular myocardium.
Topics: Amiodarone; Animals; Anisotropy; Anti-Arrhythmia Agents; Heart Conduction System; Humans; Myocardium; Pre-Excitation Syndromes; Pyrimidinones; Signal Processing, Computer-Assisted; Sodium Channel Blockers; Tachycardia, Ventricular | 2005 |
[Strategy for cardiac arrhythmias in acute coronary syndrome].
Topics: Amiodarone; Angina, Unstable; Anti-Asthmatic Agents; Aprindine; Atrial Fibrillation; Bepridil; Electric Countershock; Humans; Myocardial Infarction; Potassium Channel Blockers; Pyrimidinones; Recurrence; Syndrome; Tachycardia, Ventricular; Ventricular Fibrillation | 2006 |
8 trial(s) available for nifekalant hydrochloride and Tachycardia, Ventricular
| Article | Year |
|---|---|
The effects of nifekalant hydrochloride on the QT dispersion after direct-current defibrillation.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Electrocardiography; Female; Humans; Male; Middle Aged; Pyrimidinones; Sotalol; Tachycardia, Ventricular; Ventricular Fibrillation; Ventricular Function, Left | 2008 |
Effects of intravenous nifekalant as a lifesaving drug for severe ventricular tachyarrhythmias complicating acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Amiodarone; Anti-Arrhythmia Agents; Blood Pressure; Electrocardiography; Emergency Medical Services; Female; Heart Rate; Humans; Infusions, Intravenous; Injections, Intravenous; Lidocaine; Male; Middle Aged; Pyrimidinones; Tachycardia, Ventricular; Torsades de Pointes; Ventricular Fibrillation | 2009 |
Nifekalant hydrochloride terminating sustained ventricular tachycardia accompanied with QT dispersion prolongation.
Topics: Adult; Anti-Arrhythmia Agents; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; Pyrimidinones; Tachycardia, Ventricular; Treatment Outcome | 2010 |
Anti-arrhythmic efficacy of nifekalant hydrochloride, a pure class III anti-arrhythmic agent, in patients with healed myocardial infarction and inducible sustained ventricular tachycardia.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Electrocardiography; Electrophysiology; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Procainamide; Pyrimidinones; Tachycardia, Ventricular | 2002 |
[The efficiency of nifekalant hydrochloride for the prevention of ventricular tachycardia during cardiac surgery].
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Surgical Procedures; Female; Humans; Infusions, Intravenous; Intraoperative Complications; Male; Middle Aged; Postoperative Complications; Pyrimidinones; Tachycardia, Ventricular; Treatment Outcome | 2004 |
Nifekalant hydrochloride suppresses severe electrical storm in patients with malignant ventricular tachyarrhythmias.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Defibrillators, Implantable; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Pyrimidinones; Salvage Therapy; Tachycardia, Ventricular | 2005 |
Can nifekalant hydrochloride be used as a first-line drug for cardiopulmonary arrest (CPA)? : comparative study of out-of-hospital CPA with acidosis and in-hospital CPA without acidosis.
Topics: Acidosis; Aged; Anti-Arrhythmia Agents; Electric Countershock; Epinephrine; Female; Heart Arrest; Humans; Hydrogen-Ion Concentration; Inpatients; Male; Middle Aged; Outpatients; Potassium; Pyrimidinones; Resuscitation; Retrospective Studies; Tachycardia, Ventricular | 2006 |
Comparison of efficacy of sotalol and nifekalant for ventricular tachyarrhythmias.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electric Stimulation; Electrocardiography; Electrophysiology; Female; Heart Diseases; Humans; Male; Middle Aged; Pyrimidinones; Secondary Prevention; Sotalol; Tachycardia, Ventricular; Treatment Outcome | 2006 |
24 other study(ies) available for nifekalant hydrochloride and Tachycardia, Ventricular
| Article | Year |
|---|---|
Long-term nifekalant use in a patient with dilated cardiomyopathy and recurrent ventricular tachycardia.
Topics: Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Humans; Male; Pyrimidinones; Tachycardia, Ventricular | 2022 |
Intraprocedural Conversion Efficacy of Intravenous Nifekalant Administration for Persistent Atrial Fibrillation after Pulmonary Vein Isolation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cryosurgery; Electric Countershock; Female; Heart Atria; Humans; Infusions, Intravenous; Intraoperative Care; Intraoperative Complications; Male; Middle Aged; Organ Size; Peripheral Nerve Injuries; Phrenic Nerve; Progression-Free Survival; Prospective Studies; Pulmonary Veins; Pyrimidinones; Recurrence; Tachycardia, Ventricular; Treatment Outcome | 2020 |
Nifekalant and disopyramide in a patient with short QT syndrome: evaluation of pharmacological effects and electrophysiological properties.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Body Surface Potential Mapping; Disopyramide; Humans; Male; Pyrimidinones; Syndrome; Tachycardia, Ventricular; Treatment Outcome; Young Adult | 2008 |
Nifekalant versus lidocaine for in-hospital shock-resistant ventricular fibrillation or tachycardia.
Topics: Aged; Anti-Arrhythmia Agents; Chi-Square Distribution; Female; Humans; Lidocaine; Male; Middle Aged; Prospective Studies; Pyrimidinones; Statistics, Nonparametric; Survival Rate; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation | 2010 |
Nifekalant hydrochloride terminated electrical storms after coronary surgery.
Topics: Aged; Anti-Arrhythmia Agents; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Myocardial Infarction; Postoperative Complications; Pyrimidinones; Severity of Illness Index; Tachycardia, Ventricular; Treatment Outcome | 2010 |
[Clinical experience with intravenous administration of nifekalant hydrochloride for ventricular tachycardia in a hemodialysis patient after open heart surgery].
Topics: Aged; Anti-Arrhythmia Agents; Aortic Valve; Heart Valve Prosthesis; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Male; Postoperative Complications; Pyrimidinones; Tachycardia, Ventricular | 2010 |
Nifekalant hydrochloride for patients with cardiac arrest caused by shockable rhythm.
Topics: Anti-Arrhythmia Agents; Defibrillators; Electric Countershock; Humans; Out-of-Hospital Cardiac Arrest; Patient Admission; Pyrimidinones; Survival Rate; Tachycardia, Ventricular; Time Factors; Torsades de Pointes; Treatment Failure; Ventricular Fibrillation | 2010 |
Deep anesthesia suppresses ventricular tachyarrhythmias in rabbit model of the acquired long QT syndrome.
Topics: Adrenergic alpha-2 Receptor Agonists; Anesthesia, General; Anesthetics, Combined; Animals; Anti-Arrhythmia Agents; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Ketamine; Long QT Syndrome; Male; Methoxamine; Pyrimidinones; Rabbits; Tachycardia, Ventricular; Time Factors; Xylazine | 2011 |
[Efficacy of Nifekalant hydrochloride for life-threatening ventricular tachyarrhythmias in patients with resistance to lidocaine: a study of patients with out-of-hospital cardiac arrest].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Drug Resistance; Emergency Medical Services; Epinephrine; Female; Heart Arrest; Humans; Lidocaine; Male; Middle Aged; Prospective Studies; Pyrimidinones; Tachycardia, Ventricular; Ventricular Fibrillation | 2003 |
Nifekalant hydrochloride, a novel class III antiarrhythmic agent, suppressed postoperative recurrent ventricular tachycardia in a patient undergoing coronary artery bypass grafting and the Dor approach.
Topics: Aged; Anti-Arrhythmia Agents; Coronary Artery Bypass; Drug Resistance; Electric Countershock; Electrocardiography; Humans; Lidocaine; Male; Mexiletine; Potassium Channel Blockers; Pyrimidinones; Tachycardia, Ventricular | 2003 |
Intravenous administration of nifekalant hydrochloride for the prevention of ischemia-induced ventricular tachyarrhythmia in patients with renal failure undergoing hemodialysis.
Topics: Aged; Anti-Arrhythmia Agents; Diabetic Nephropathies; Drug Monitoring; Electrocardiography; Humans; Injections, Intravenous; Male; Myocardial Ischemia; Pyrimidinones; Renal Dialysis; Renal Insufficiency; Tachycardia, Ventricular | 2003 |
Experience with nifekalant hydrochloride in a patient with ischemic cardiomyopathy and severe ventricular dysfunction after dor operation.
Topics: Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Cardiomyopathies; Electric Countershock; Humans; Male; Middle Aged; Myocardial Ischemia; Pyrimidinones; Tachycardia, Ventricular; Treatment Outcome; Ventricular Dysfunction, Left | 2004 |
[Nifekalant hydrochloride as an effective treatment for postoperative ischemic heart disease].
Topics: Aged; Anti-Arrhythmia Agents; Coronary Artery Bypass; Female; Humans; Injections, Intravenous; Male; Myocardial Ischemia; Postoperative Complications; Pyrimidinones; Tachycardia, Ventricular | 2005 |
Efficacy of nifekalant hydrochloride in the treatment of fatal ventricular arrhythmia in patients with ischemic heart disease.
Topics: Aged; Anti-Arrhythmia Agents; Drug Administration Schedule; Electrocardiography; Female; Humans; Male; Multivariate Analysis; Myocardial Ischemia; Prognosis; Pyrimidinones; Survival Rate; Tachycardia, Ventricular; Ventricular Fibrillation | 2005 |
[Treatment for perioperative arrhythmias with nifekalant hydrochloride].
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Flutter; Cardiac Surgical Procedures; Female; Humans; Male; Middle Aged; Postoperative Complications; Pyrimidinones; Tachycardia, Ventricular; Ventricular Fibrillation | 2006 |
Mechanisms of destabilization and early termination of spiral wave reentry in the ventricle by a class III antiarrhythmic agent, nifekalant.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Female; Heart Conduction System; Heart Ventricles; Male; Pyrimidinones; Rabbits; Tachycardia, Ventricular; Treatment Outcome | 2007 |
Nifekalant hydrochloride administration during cardiopulmonary resuscitation improves the transmural dispersion of myocardial repolarization: experimental study in a canine model of cardiopulmonary arrest.
Topics: Animals; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Disease Models, Animal; Dogs; Heart Arrest; Heart Conduction System; Humans; Pyrimidinones; Tachycardia, Ventricular; Ventricular Fibrillation | 2006 |
[Nifekalant hydrochloride effective against perioperative ventricular tachycardia in patients with impaired left ventricular function].
Topics: Adult; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Electrocardiography; Female; Humans; Male; Perioperative Care; Pyrimidinones; Tachycardia, Ventricular; Ventricular Function, Left | 2007 |
[Despite medication, overdrive pacing is required to stabilize the electrical storm associated with acute coronary syndrome: a case report].
Topics: Acute Coronary Syndrome; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Drug Resistance; Female; Humans; Myocardial Infarction; Pyrimidinones; Stents; Tachycardia, Ventricular; Treatment Outcome | 2007 |
Effects of MS-551, a new class III antiarrhythmic drug, on programmed stimulation-induced ventricular arrhythmias, electrophysiology, and hemodynamics in a canine myocardial infarction model.
Topics: Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Dogs; Electrocardiography; Hemodynamics; Myocardial Infarction; Pyrimidinones; Refractory Period, Electrophysiological; Tachycardia, Ventricular | 1994 |
Effects of class I and III antiarrhythmic drugs on ventricular tachycardia-interrupting critical paced cycle length with rapid pacing.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Child; Electrophysiology; Female; Heart Conduction System; Humans; Male; Middle Aged; Piperidines; Pyridines; Pyrimidinones; Tachycardia, Ventricular | 1998 |
Electrophysiologic effects of intravenous MS-551, a novel class III antiarrhythmic agent, on human atrium and ventricle.
Topics: Adolescent; Adult; Analysis of Variance; Anti-Arrhythmia Agents; Drug Evaluation; Electrocardiography; Electrophysiology; Female; Heart; Heart Atria; Heart Ventricles; Humans; Infusions, Intravenous; Male; Middle Aged; Pyrimidinones; Tachycardia, Ventricular | 1998 |
Comparison of electrophysiologic effects of intravenous E-4031 and MS-551, novel class III antiarrhythmic agents, in patients with ventricular tachyarrhythmias.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Heart Ventricles; Humans; Infusions, Intravenous; Male; Middle Aged; Piperidines; Pyridines; Pyrimidinones; Tachycardia, Ventricular; Treatment Outcome | 1998 |
Reverse use-dependent QT prolongation during infusion of nifekalant in a case of recurrent ventricular tachycardia with old myocardial infarction.
Topics: Anti-Arrhythmia Agents; Electrocardiography; Heart Ventricles; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Pyrimidinones; Tachycardia, Ventricular | 2001 |